The ACIP green lights mRNA vaccines with warning for myocarditis and pericarditis, says COVID-19 vaccine can be given on the same day as other common vaccines, advises COVID vaccine for all aged ≥12 yrs.
FDA Grants Novavax COVID-19 Vaccine Full Approval for High-Risk Groups
Nuvaxovid (NVX-CoV2373) is indicated for those aged ≥65 years and aged 12 to 64 years with at least one condition that puts them at high risk for severe infection.
Weekly Dose: A Roundup of Top Stories for Primary Care Physicians
PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.
Bacterial Vaginosis Recurrence Drops with Partner Treatment: Daily Dose
Your daily dose of the clinical news you may have missed.
Primary Viewpoints: Immunizations with Dr Steven P. Furr
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.
Novavax JN.1 COVID-19 Vaccine Linked to Fewer Side Effects Than mRNA in Health Care Workers
Novavax’s COVID-19 vaccine was linked to fewer and less severe side effects vs mRNA in a University of Utah study of health care workers.
Oral Gepotidacin Noninferior to Standard Therapy for Gonorrhea in Phase 3 Trial
Data from the EAGLE-1 study found gepotidacin to be noninferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.